- Home
- TPCS vs LVTX Comparison
TPCS vs LVTX Comparison
Compare TPCS & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPCS
- LVTX
- Stock Information
- Founded
- TPCS 1956
- LVTX 2016
- Country
- TPCS United States
- LVTX Netherlands
- Employees
- TPCS N/A
- LVTX N/A
- Industry
- TPCS Metal Fabrications
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- TPCS Industrials
- LVTX Health Care
- Exchange
- TPCS Nasdaq
- LVTX Nasdaq
- Market Cap
- TPCS 27.2M
- LVTX 27.9M
- IPO Year
- TPCS N/A
- LVTX 2021
- Fundamental
- Price
- TPCS $2.63
- LVTX $1.32
- Analyst Decision
- TPCS
- LVTX Hold
- Analyst Count
- TPCS 0
- LVTX 3
- Target Price
- TPCS N/A
- LVTX $3.17
- AVG Volume (30 Days)
- TPCS 48.3K
- LVTX 1.2M
- Earning Date
- TPCS 01-21-2025
- LVTX 03-19-2025
- Dividend Yield
- TPCS N/A
- LVTX N/A
- EPS Growth
- TPCS N/A
- LVTX N/A
- EPS
- TPCS N/A
- LVTX N/A
- Revenue
- TPCS $33,182,059.00
- LVTX $7,345,000.00
- Revenue This Year
- TPCS N/A
- LVTX $16.68
- Revenue Next Year
- TPCS N/A
- LVTX N/A
- P/E Ratio
- TPCS N/A
- LVTX N/A
- Revenue Growth
- TPCS 6.44
- LVTX N/A
- 52 Week Low
- TPCS $2.16
- LVTX $0.85
- 52 Week High
- TPCS $5.95
- LVTX $4.21
- Technical
- Relative Strength Index (RSI)
- TPCS 36.56
- LVTX 65.81
- Support Level
- TPCS $2.58
- LVTX $1.25
- Resistance Level
- TPCS $3.00
- LVTX $1.51
- Average True Range (ATR)
- TPCS 0.25
- LVTX 0.09
- MACD
- TPCS -0.01
- LVTX 0.02
- Stochastic Oscillator
- TPCS 50.00
- LVTX 72.88
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.